Interventional approach to congenital heart disease

Current Opinion in Cardiology

Volumn 19, Issue 2, 2004, Pages 84-90

  Holzer, Ralf ^a   Hijazi, Ziyad M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atrial septal defects; Branch pulmonary artery stenosis; Percutaneous pulmonic valve; Ventricular septal defect

Indexed keywords

ADULT; CATHETER; CONGENITAL HEART DISEASE; DEVICE; FENESTRATION; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; PRIORITY JOURNAL; REVIEW; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; CARDIOVASCULAR SURGICAL PROCEDURES; CHILD; CLINICAL TRIALS; DUCTUS ARTERIOSUS, PATENT; EQUIPMENT DESIGN; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HEART VALVE PROSTHESIS; HUMANS; INFANT; STENTS;

EID: 1642399800     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200403000-00003     Document Type: Review

References (48)

1. Thanopoulos BD, Tsaousis GS, Karanasios E, et al.: Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children. Heart 2003, 89:918-922. This interesting report outlines the most recent experience using the Amplatzer membranous VSD device (pediatric patients only).
2. Bass JL, Kalra GS, Arora R, et al.: Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv 2003, 58:238-245. This important article reports recent experience of VSD device closure using the Amplatzer membranous VSD device (mainly pediatric patients, few adults).
3. Arora R, Trehan V, Kumar A, et al.: Transcatheter closure of congenital ventricular septal defects: experience with various devices. J Interv Cardiol 2003, 16:83-91. This is a report of the largest published experience with VSD device closure to date (mainly pediatric patients, few adults).
4. Holzer RJ, Hijazi ZM, Wilkinson J, et al.: Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder: immediate results [abstract]. Catheter Cardiovasc Interv 2003, 60:123.
5. Amin Z, Danford DA: Modification of Amplatzer device and delivery system to improve placement in the ventricular septal defects [abstract]. Catheter Cardiovasc Interv 2003, 60:125
6. Holzer RJ, Balzer D, Cao QL, et al.: Device closure of muscular ventricular septal defects using the Amplatzer muscular VSD occluder: immediate and mid term results of a US Registry. J Am Coll Cardiol 2003, in press. This very important article describes in great detail the results of the US registry of the Amplatzer muscular VSD device (mainly pediatric patients, few adults).
7. Holzer RJ, Balzer D, Amin Z, et al.: Transcatheter closure of post infarction ventricular septal defects using the new Amplatzer muscular VSD occluder: results of a US Registry. Catheter Cardiovasc Interv 2003, in press. This reports on the most experience using the Amplatzer postinfarction VSD device to date (adult patients only).
8. Szkutnik M, Bialkowski J, Kusa J, et al.: Postinfarction ventricular septal defect closure with Amplatzer occluders. Eur J Cardiothorac Surg 2003, 23:323-327. This article reports recent experience of device closure of post infarction VSDs in nonacute patients (adult patients only).
9. Goldstein JA, Casserly IP, Balzer DT, et al.: Transcatheter closure of recurrent postmyocardial infarction ventricular septal defects utilizing the Amplatzer postinfarction VSD device: a case series. Catheter Cardiovasc Interv 2003, 59:238-243. Successful closure of recurrent postinfarction VSDs in four nonacute patients after initial surgical closure is reported (adult patients only).
10. Rigby ML, Redington AN: Primary transcatheter umbrella closure of perimembranous ventricular septal defect. Br Heart J 1994, 72:368-371. This article describes early experience with device closure of perimembranous VSDs (pediatric patients only).
11. 10a Du DZ, Koenig P, Cao QL, et al.: Comparison of transcatheter closure of secundum atrial septal defect using the amplatzer septal occluder associated with deficient-vs-sufficient rims. Am J Cardiol 2002, 90:865-869.
12. Tortoriello TA, McMahon C, Kovalchin JP, et al.: Growth of an atrial septal defect: missing the window for transcatheter closure. Pediatr Cardiol 2002, 23:542-544. This article highlights the potential for enlargement of ASDs, which can render a transcatheter approach unsuitable (pediatric patients only).
13. Sideris EB, Sideris CE, Stamatelopoulos SF, et al.: Transcatheter patch occlusion of experimental atrial septal defects. Catheter Cardiovasc Interv 2002, 57:404-407. A new approach to ASD closure using patch and specified balloon catheters is described (animal study).
14. Trepels T, Zeplin H, Sievert H, et al.: Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv 2003, 58:111-113.
15. Amin Z, Danford DA, Pedra CA: A new Amplatzer device to maintain patency of Fontan fenestrations and atrial septal defects. Catheter Cardiovasc Interv 2002, 57:246-251. This article describes the fenestrated Amplatzer septal occluder (pediatric patients only).
16. Cheatham JP, Hill SL, Chisolm JL: Initial results using the new cribriform Amplatzer septal occluder for transcatheter closure of multifenestrated atrial septal defects with septal aneurysm [abstract]. Catheter Cardiovasc Interv 2003, 60:126.
17. Onorato E, Melzi G, Casilli F, et al.: Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Interv Cardiol 2003, 16:43-50. This article reports a large cohort of patients who underwent patent foramen ovale device closure (mainly adult patients, few pediatric patients).
18. Morandi E, Anzola GP, Angeli S, et al.: Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003, 16:39-42. This is a very important article because it suggests a potential new indication for patent foramen ovale device closure (mainly adult patients).
19. Ebeid MR, Masura J, Hijazi ZM: Early experience with the Amplatzer ductal occluder for closure of the persistently patent ductus arteriosus. J Interv Cardiol 2001, 14:33-36.
20. Ewert P, Kretschmar O, Nuernberg JH, et al.: First closure of a large patent ductus arteriosus in an infant with an angulated nitinol plug. Catheter Cardiovasc Interv 2002, 57:88-91. This is the first description of use of the angulated Amplatzer ductal occluder in pediatric patients.
21. Masura J, Gavora P, Podnar T: Transcatheter occlusion of patent ductus asteriosus using a new angled Amplatzer duct occluder: initial clinical experience. Catheter Cardiovasc Interv 2003, 58:261-267. This series of patients underwent patent ductus arteriosus device closure using the new angulated Amplatzer ductal occluder with excellent results (pediatric patents only).
22. Chisolm JL, Hill SL, Hardin J, et al.: Initial experience with the Nit-Occlud PDA occlusion system for closure of patent ductus arteriosus [abstract]. Catheter Cardiovasc Interv 2003, 60:123.
23. Trivedi KR, Benson LN: Interventional strategies in the management of peripheral pulmonary artery stenosis. J Interv Cardiol 2003, 16:171-188. This excellent review outlines the current strategies in management of branch pulmonary artery stenosis, based on mainly pediatric patients.
24. 22a Bergersen LJ, Perry SB, Lock JE. Effect of cutting balloon angioplasty on resistant pulmonary artery stenosis. Am J Cardiol 2003, 91:185-189.
25. Rao PS, Jureidini SB, Balfour IC, et al.: Severe aortic coarctation in infants less than 3 months: successful palliation by balloon angioplasty. J Invasive Cardiol 2003, 15:202-208. This series is very important because it describes the successful transcatheter management of native coarctation in a larger number of children younger than 3 months of age (pediatric patients only).
26. Radtke WA, Waller BR, Hebra A, et al.: Palliative stent implantation for aortic coarctation in premature infants weighing <1,500 g. Am J Cardiol 2002, 90:1409-1412. This article demonstrates that palliative stent implantation using an approach with carotid cutdown is feasible in small infants (pediatric patients only).
27. Ewert P, Kretschmar O, Nuernberg JH, et al.: Transcatheter therapy of coarctation of the aorta by the use of the Cheatham-Platinum-Stent [abstract]. Catheter Cardiovasc Interv 2003, 60:129.
28. Bell RE, Taylor PR, Aukett M, et al.: Endoluminal repair of aneurysms associated with coarctation. Ann Thorac Surg 2003, 75:530-533. This article highlights the benefits of covered stents in treating aneurysms associated with coarctation of the aorta (adult patients only).
29. Boudjemline Y, Agnoletti G, Piechaud JF, et al.: [Percutaneous pulmonary valve replacement: towards a modification of the prosthesis.] Arch Mal Coeur Vaiss 2003, 96:461-466.
30. Zhou JQ, Corno AF, Huber CH, et al.: Self-expandable valved stent of large size: off-bypass implantation in pulmonary position. Eur J Cardiothorac Surg 2003, 24:212-216. This important article highlights a novel periventricular approach to implant valved stents in pulmonary position (animal study).
31. Cribier A, Eltchaninoff H, Bash A, et al.: Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106:3006-3008. This is the report of the first successful transcatheter implantation of a valved stent in aortic position using a transseptal approach (adult patients only).
32. Hjortdal VE, Redington AN, de Levai MR, et al.: Hybrid approaches to complex congenital cardiac surgery. Eur J Cardiothorac Surg 2002, 22:885-890. This interesting article outlines many variants of the hybrid approach to congenital heart disease (mainly pediatric patients, few adults).
33. Bacha E, Cao QL, Starr JP, et al.: Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. J Thorac Cardiovasc Surg 2003, in press. This very important article is the first to highlight a novel periventricular approach to close muscular VSDs without the use of cardiopulmonary bypass (pediatric patients only).
34. Michel-Behnke I, Akintuerk H, Marquardt I, et al.: Stenting of the ductus arteriosus and banding of the pulmonary arteries: basis for various surgical strategies in newborns with multiple left heart obstructive lesions. Heart 2003, 89:645-650. This important article presents one center's experience with treating 20 patients with left heart obstructive lesions using percutaneous ductal stenting and surgical bilateral pulmonary artery banding (pediatric patients only).
35. Block PC: Percutaneous mitral valve repair for mitral regurgitation. J Interv Cardiol 2003, 16:93-96.
36. Lutterman J, Koopot R: Transcatheter treatment of obstructed modified Blalock-Taussig shunts [abstract]. Catheter Cardiovasc Interv 2003, 60:134.
37. Forbes TJ, Rodriguez-Cruz E, Amin Z, et al.: The Genesis stent: a new low-profile stent for use in infants, children, and adults with congenital heart disease. Catheter Cardiovasc Interv 2003, 59:406-414. This article describes a newly modified version of the Genesis stent.
38. Ewert P, Kretschmar O, Riesenkampff E, et al.: First experience with a new reexpandable "growth stent" for the treatment of vessel stenosis in infants and small children [abstract]. Catheter Cardiovasc Interv 2003, 60:125.
39. Agnoletti G, Boudjemline Y, Largen E, et al.: Use of 3Fr catheters for diagnostic and interventional procedures in newborns and small infants [abstract]. Catheter Cardiovasc Interv 2003, 60:140.
40. Froemming S, Fletcher SE, Amin Z: A new technique for direct pulmonary artery pressure measurement in shunt dependent cardiac lesions [abstract]. Catheter Cardiovasc Interv 2003, 60:138.
41. Veldtman G, Peirone A, Benson LN: Radiofrequency perforation of the atrial septum: preliminary experimental evaluation and development [abstract]. Catheter Cardiovasc Interv 2003, 60:132.
42. Daehnert I, Rotzsch C: Rapid right ventricular pacing as an alternative to adenosine in interventions for congenital heart disease [abstract]. Catheter Cardiovasc Interv 2003, 60:133.
43. Mullen MJ, Dias BF, Walker F, et al.: Intracardiac echocardiography guided device closure of atrial septal defects. J Am Coll Cardiol 2003, 41:285-292. This is a series of intracardiac echocardiography to facilitate ASD device closure (adult patients only).
44. Koenig P, Cao QL, Heitschmidt M, et al.: Role of intracardiac echocardiographic guidance in transcatheter closure of atrial septal defects and patent foramen ovale using the Amplatzer device. J Interv Cardiol 2003, 16:51-62. This is the largest series of intracardiac echocardiography used in ASD device closure to date (predominantly adults, mixed patients).
45. Bartel T, Konorza T, Arjumand J, et al.: Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation 2003, 107:795-797. This series compares intracardiac echocardiography with transesophageal echocardiography to facilitate ASD device closure (adult patients only).
46. Acar P, Roux D, Dulac Y, et al.: Transthoracic three-dimensional echocardiography prior to closure of atrial septal defects in children. Cardiol Young 2003, 13:58-63. This article describes three-dimensional echocardiography and ASD device closure (mainly pediatric patients).
47. Acar P, Abdel-Massih T, Douste-Blazy MY, et al.: Assessment of muscular ventricular septal defect closure by transcatheter or surgical approach: a three-dimensional echocardiographic study. Eur J Echocardiogr 2002, 3:185-191. This article discusses the potential of three-dimensional echocardiography in cardiac interventions (mainly pediatric patients, few adults).
48. Rickers C, Seethamraju RT, Jerosch-Herold M, et al.: Magnetic resonance imaging guided cardiovascular interventions in congenital heart diseases. J Interv Cardiol 2003, 16:143-147. This article highlights and describes the potentials and limitations of cardiac interventions under MRI guidance.